brentuximab vedotin

Takeda seeks Japanese approval for brentuximab vedotin to treat relapsed/refractory CD30 positive HL and ALCL
Pharmabiz
Sat, 03/23/13 - 10:15 am
Takeda
brentuximab vedotin
systemic anaplastic large cell lymphoma
The Big Bet on Seattle Genetics
Motley Fool
Tue, 07/12/11 - 12:13 pm
Seattle Genetics
brentuximab vedotin
Hodgkin's lymphoma
FDA committee to review Seattle Genetics cancer drug applications in July
bizjournals.com
Thu, 06/16/11 - 10:19 pm
FDA
Seattle Genetics
brentuximab vedotin
Millennium and Seattle Genetics Announce Brentuximab Vedotin (SGN-35) Presentations at 16th Congress of the European Hematology Association
Yahoo/BusinessWire
Sat, 05/28/11 - 11:56 am
Millennium
Seattle Genetics
brentuximab vedotin
SGN-35
Hodgkin's lymphoma
Seattle Genetics says FDA will make two rulings on its cancer drug brentuximab by Aug. 30
Yahoo/AP
Mon, 05/2/11 - 12:39 pm
FDA
brentuximab vedotin
Seattle Genetics
Hodgkin's lymphoma
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir
Seattle Genetics and Millennium Report Positive Data from Pivotal Trial of Brentuximab Vedotin (SGN-35) in Relapsed or Refractory Hodgkin Lymphoma at ASH Annual Meeting
Yahoo/BusinessWire
Sun, 12/5/10 - 11:47 am
Seattle Genetics
Millennium
brentuximab vedotin
SGN-35
Hodgkin's lymphoma
Takeda
Is Seattle Genetics the Next Big Thing?
Minyanville
Thu, 12/2/10 - 04:47 pm
Seattle Genetics
brentuximab vedotin
lymphoma
Now That's What I Call a Drug That Works (Seattle Genetics)
Motley Fool
Tue, 09/28/10 - 07:45 am
Seattle Genetics
brentuximab vedotin
Hodgkin's lymphoma
Seattle Genetics, Takeda & Millennium begin phase-III Aethera trial of brentuximab vedotin for post-transplant Hodgkin lymphoma
Pharmabiz
Sat, 04/10/10 - 12:45 pm
Seattle Genetics
Takeda
brentuximab vedotin
Hodgkin's lymphoma